LMB-2 Immunotoxin and Vaccine Therapy in Treating Patients With Metastatic Melanoma That Cannot Be Removed By Surgery

Clinical trial NCT00295958 · COMPLETED

Trial details

NCT number: NCT00295958
Sponsor: National Institutes of Health Clinical Center (CC)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma (Skin)Non-melanomatous Skin Cancer

Start date: 2005-12-01
Primary completion: 2006-06-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.